Premature release of data from clinical trials of ezetimibe.
Califf
Robert M
RM
Duke Translational Medicine Institute, Durham, NC, USA.
Harrington
Robert A
RA
Blazing
Michael A
MA
D016907:Adverse Drug Reaction Reporting Systems / Q000592:standards; D000924:Anticholesteremic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001384:Azetidines / Q000009:adverse effects* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000517:prevention & control; D008078:Cholesterol, LDL / Q000097:blood; D019992:Databases as Topic; D017277:Drug Approval; D004359:Drug Therapy, Combination; D000069438:Ezetimibe; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D015994:Incidence; D009369:Neoplasms / Q000139:chemically induced*; D016032:Randomized Controlled Trials as Topic / Q000191:economics / Q000592:standards*; D012042:Registries; D019821:Simvastatin / Q000627:therapeutic use; D014481:United States
D000924:Anticholesteremic Agents; D001384:Azetidines; D008078:Cholesterol, LDL; D019821:Simvastatin; D000069438:Ezetimibe